Moreover, in the insulin resistant condition, the liver does not suppress hepatic glucose production in response to insulin and increases de novo lipogenesis, activating the Notch signaling pathway; [49] in fact, in subjects with NAFLD the increase in de novo lipogenesis is 5-fold higher than in healthy subjects [49]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.